Phase 1/phase 2 clinical trial
Term · Oncology and biomedicine · MLC-T-ONC-006591
A study that tests the safety, side effects, and best dose of a new treatment. Phase 1/phase 2 clinical trials also test how well a certain type of cancer or other disease responds to a new treatment. In the phase 2 part of the clinical trial, patients usually receive the highest dose of treatment that did not cause harmful side effects in the phase 1 part of the clinical trial. Combining phases 1 and 2 may allow research questions to be answered more quickly or with fewer patients. Also called phase I/II clinical trial.
| Identifier | MLC-T-ONC-006591 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | phase I/II clinical trial |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-006591",
"term": "Phase 1/phase 2 clinical trial",
"field": "Oncology and biomedicine",
"definition": "A study that tests the safety, side effects, and best dose of a new treatment. Phase 1/phase 2 clinical trials also test how well a certain type of cancer or other disease responds to a new treatment. In the phase 2 part of the clinical trial, patients usually receive the highest dose of treatment that did not cause harmful side effects in the phase 1 part of the clinical trial. Combining phases 1 and 2 may allow research questions to be answered more quickly or with fewer patients. Also called phase I/II clinical trial.",
"synonyms": [
"phase I/II clinical trial"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/phase-1-phase-2-clinical-trial/"
}
Record 13,082 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.